|
Jun 2017
As of Jun 30, 2017
|
Mar 2017
As of Mar 31, 2017
|
Sep 2016
As of Sep 30, 2016
|
Mar 2016
As of Mar 31, 2016
|
Dec 2015
As of Dec 31, 2015
|
Jun 2015
As of Jun 30, 2015
|
Mar 2015
As of Mar 31, 2015
|
Dec 2014
As of Dec 31, 2014
|
Sep 2014
As of Sep 30, 2014
|
Jun 2014
As of Jun 30, 2014
|
Mar 2014
As of Mar 31, 2014
|
Sep 2013
As of Sep 30, 2013
|
Dec 2013
As of Dec 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current assets | |||||||||||||
| Cash and equivalents | |||||||||||||
| Total current assets | |||||||||||||
| Equipment, net | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||||||||
| Accounts payable and accrued expenses | |||||||||||||
| Loans payable - stockholders | |||||||||||||
| Accrued interest | |||||||||||||
| Current liabilities | |||||||||||||
| Accrued expenses | |||||||||||||
| Loan payable - stockholder | |||||||||||||
| Note payable - current portion | |||||||||||||
| Total current liabilities | |||||||||||||
| Note payable - net of current portion | |||||||||||||
| Note payable | |||||||||||||
| Total liabilities | |||||||||||||
| Commitments and Contingencies | |||||||||||||
| Stockholders' (deficit) | |||||||||||||
| Preferred stock, no par value; 10,000,000 shares authorized, no shares issued and outstanding | |||||||||||||
| Common stock, $0.0001 par value; 500,000,000 shares authorized, 247,240 and 247,240 shares issued and outstanding, respectively | |||||||||||||
| Additional paid in capital | |||||||||||||
| Deficit accumulated during development stage | |||||||||||||
| Common stock to-be-issued | |||||||||||||
| Treasury stock | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders' deficit | |||||||||||||
| Total liabilities and stockholders deficit | |||||||||||||
Loading...
